Similar articles for PMID: 25384122

Year	Number of Results
2005	1
2006	1
2008	3
2009	3
2010	2
2011	3
2012	12
2013	15
2014	14
2015	22
2016	12
2017	10
2018	9
2019	3
2020	6
2021	1
2022	2
2023	2
2024	0

1

Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.

Nie W, Xu MD, Gan L, Huang H, Xiu Q, Li B. Nie W, et al. Lab Invest. 2015 Jan;95(1):56-64. doi: 10.1038/labinvest.2014.124. Epub 2014 Nov 10. Lab Invest. 2015. PMID: 25384122 Free article.

2

High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.

Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H. Bao P, et al. Ann Surg Oncol. 2017 Dec;24(13):4017-4024. doi: 10.1245/s10434-017-6083-0. Epub 2017 Sep 20. Ann Surg Oncol. 2017. PMID: 28933054

3

Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.

Li J, Hu G, Kong F, Wu K, Song K, He J, Sun W. Li J, et al. Pathol Oncol Res. 2015 Sep;21(4):1013-20. doi: 10.1007/s12253-015-9930-y. Epub 2015 Mar 20. Pathol Oncol Res. 2015. PMID: 25791566 Free article.

4

Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.

Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, Mogi A, Hirato J, Nishiyama M, Shirabe K. Shimizu K, et al. Ann Thorac Surg. 2019 Jul;108(1):235-243. doi: 10.1016/j.athoracsur.2019.02.040. Epub 2019 Mar 22. Ann Thorac Surg. 2019. PMID: 30910656

5

Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.

Rong B, Nan Y, Liu H, Gao W. Rong B, et al. Cancer Biomark. 2017;19(1):35-43. doi: 10.3233/CBM-160239. Cancer Biomark. 2017. PMID: 28282798

6

An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.

Zhao C, Li H, Wang L, Sun W. Zhao C, et al. Med Sci Monit. 2018 Aug 31;24:6070-6078. doi: 10.12659/MSM.910953. Med Sci Monit. 2018. PMID: 30169496 Free PMC article.

7

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL. Chen YL, et al. Ann Surg Oncol. 2013 Nov;20(12):4041-54. doi: 10.1245/s10434-012-2519-8. Epub 2012 Aug 22. Ann Surg Oncol. 2013. PMID: 22911364

8

Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.

Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY. Ni PZ, et al. Oncol Rep. 2017 Dec;38(6):3608-3618. doi: 10.3892/or.2017.6039. Epub 2017 Oct 17. Oncol Rep. 2017. PMID: 29039594

9

Expression of TS, RRM1, ERCC1, TUBB3 and STMN1 Genes in Tissues of Non-small Cell Lung Cancer and its Significance in Guiding Postoperative Adjuvant Chemotherapy.

Zou ZQ, Du YY, Sui G, Xu SN. Zou ZQ, et al. Asian Pac J Cancer Prev. 2015;16(8):3189-94. doi: 10.7314/apjcp.2015.16.8.3189. Asian Pac J Cancer Prev. 2015. PMID: 25921119 Free article.

10

Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.

He X, Liao Y, Lu W, Xu G, Tong H, Ke J, Wan X. He X, et al. Tumour Biol. 2016 Jul;37(7):9951-8. doi: 10.1007/s13277-016-4869-5. Epub 2016 Jan 27. Tumour Biol. 2016. PMID: 26815505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year